scorecardresearch
Friday, April 26, 2024
TopicVaccine

Topic: Vaccine

Indian economy can see V-shaped recovery if Covid vaccine is found this year: CEA Subramanian

In the absence of a vaccine, the economic recovery will have to wait until next year, although that too is likely to be V-shaped, CEA Krishnamurthy Subramanian said.

Second UK vaccine to combat coronavirus to begin human testing this week

If the vaccine yields a promising immune response, larger trials will begin later in the year with about 6,000 volunteers.

Now, Johnson & Johnson speeds up Covid vaccine trials in ‘race against time’

Johnson & Johnson will start human trials in the second half of July, about two months earlier than expected. Final-stage tests could begin in September.

Bill Gates invests in mass production of Covid vaccine so poor countries will get a shot

Gates is focusing on the most promising vaccine candidates, committing funds to help ensure production capacity is ready even before any have proven to work.

Why coronavirus treatments shouldn’t take back seat to vaccines

Everything would have to go right to get a vaccine this year, but several types of treatments may be able to help patients in a matter of months.

Not Oxford lab, not US company, Covid solution will come from India, China pharma industry

Fast and mass pharma production in India and China is crucial if the coronavirus pandemic is to be brought under control.

Are people who have had Covid-19 immune? Perhaps not

What needs to happen now is a series of studies to determine whether the presence of antibodies is associated with protection against re-infection with SARS-CoV-2.

Covid vaccine makers may need to infect subjects to get results

As the infection rate changes, companies running drug trials will face a new problem — not enough test subjects in their regions.

Indian vaccine ventures with global partners could move to human trials soon: VijayRaghavan

At least 14 vaccine candidates being developed solely by Indian players, but none ready for human trials stage yet, Principal Scientific Adviser K. VijayRaghavan says.

Why vaccines should not be immune to market forces

Market prices for vaccines could ensure additional production, help differentiate between vaccines, and even allocation of resources.

On Camera

Why the future of cars does not look electrified

Making a jump from internal combustion engines to electric vehicles is the kind of romantic prospect that would appeal to India, which jumped from a shortage of landline phones to an abundance of smartphones.

Notices, fines, court case & now a limited ban — RBI-Kotak relationship has been fraught for years

RBI Wednesday banned Kotak Mahindra Bank from taking on new customers through digital channels & from issuing new credit cards. Violations had to do with strength of bank’s IT infra.

Rafale to Exercise Garuda, a look at Indo-French defence ties as Chief of Defence Staff visits France

Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.